window-to-japan.eu

Window to Japan

OncoTherapy Science announces stop of phase III study on COMPETE-PC, its pancreatic cancer-directed cocktail vaccine C01

Posted in News By schmid_wordpressPosted on

Clinical efficacy is not sufficiently higher as compared to control group.

OncoTherapy Science press release, December 20, 2013

OncoTherapy Science announces stop of phase III study on COMPETE-PC, its pancreatic cancer-directed cocktail vaccine C01
Scroll to top